Skip to content

Study to check the safety and performance of the EYECRYL PLUS 600 lens in participants undergoing cataract surgery.

A Prospective, single arm, multicentric, clinical study of EYECRYL PLUS (600) intraocular lens to assess performance and safety in patients undergoing cataract surgery. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092305
Enrollment
375
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: EYECRYL PLUS (600) intraocular lens: Total duration of study is 24 months, visit schedule is Pre-operative Visit/Screening Visit Surgery Visit Post-operative 1 to 2 Days Post-operative

Sponsors

Biotech vision care pvt ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult patient, 18 years old or older will be enrolled in the study 2 Patient with cataract 3 Calculated IOL power is within the range of the study IOL 4 Patients must sign and be given a copy of the written Informed Consent form 5 Clear intraocular media other than cataract 6 Patient willing to undergo the investigations and comply with the follow-up schedule

Exclusion criteria

Exclusion criteria: 1 Previous intraocular or corneal surgery 2 Pregnancy or lactation 3 Concurrent participation or participation in the last 30 days in any other clinical trial 4 Irregular astigmatism 5 instability of keratometry or biometry measurements 6 Vulnerable subjects 7 Patients receiving chloroquine treatment

Design outcomes

Primary

MeasureTime frame
Percentage of subject achieving distance corrected visual acuity of 0.3 logMAR or better at 12 months post operatively.Timepoint: 12 months post operatively

Secondary

MeasureTime frame
Percentage of best-case subjects achieving best corrected distance visual acuity of 0.3 logMAR or better at 12 months post operatively.Timepoint: 12 months post operatively.

Countries

India

Contacts

Public ContactMR BHARGAV JOSHI

BIOTECH VISION CARE PVT LTD

bhargav.joshi@biotechhealthcare.com09925925667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026